Disease Focus: Vision Loss


Blindness: Advancing Stem Cell Therapies – 2011 CIRM Grantee Meeting

Dennis Clegg speaks at the 2011 CIRM Grantee Meeting about the development of a stem-cell based therapy for macular degeneration, the leading cause of blindness in the elderly. Clegg is co-director of UC Santa Barbara’s Center for Stem Cell Biology and Engineering.

Cures through Collaboration: Funding a Team Approach to Disease Research

Both the Guthy-Jackson Charitable Foundation (GJCF) and the California Institute for Regenerative Medicine (CIRM) share a similar vision for funding a team approach to disease research. When Victoria Jackson’s daughter, Ali, was diagnosed with NMO – a rare incurable disease that can lead to blindness, paralysis and even death – Jackson created the GJCF and […]

Video – Spotlight on Stem Cell Research: Devic’s Disease (NMO) – Introduction

Robert Klein, J.D. and Sherry Lansing introduced the speakers for the “Spotlight on Devic’s Disease (NMO),” an educational event presented at the CIRM Governing Board meeting on October 21, 2010. Klein is chair of the CIRM Governing Board. Lansing is a member of the CIRM Governing Board and the founder and chair of the Sherry […]

Video – Spotlight on Stem Cell Research: Devic’s Disease (NMO) – Victoria Jackson

Victoria Jackson spoke at the “Spotlight on Devic’s Disease (NMO),” an educational event presented at the CIRM Governing Board meeting on October 21, 2010. Jackson is the founder of the Guthy-Jackson Charitable Foundation which funds research with the aim of finding a cure for neuromyelitis optica (NMO). Sherry Lansing, a member of the CIRM¬†Governing Board, […]

Video – Spotlight on Stem Cell Research: Devic’s Disease (NMO) – Michael Yeaman

MIchael Yeaman, Ph.D. spoke at the “Spotlight on Devic’s Disease (NMO),” an educational event presented at the CIRM Governing Board meeting on October 21, 2010. Yeaman is a professor of medicine in the Division of Infectious Diseases at the University of California, Los Angeles. Victoria Jackson, founder of the Guthy-Jackson Charitable Foundation, introduced Yeaman. The […]

Video – Spotlight on Stem Cell Research: Devic’s Disease (NMO) – Benjamin Greenberg

Benjamin Greenberg, M.D., MHSc, spoke at the “Spotlight on Devic’s Disease (NMO),” an educational event presented at the CIRM Governing Board meeting on October 21, 2010. Greenberg is director of the Neuromyelitis Optica Program at the University of Texas, Southwestern Medical School. Greenberg was introduced by Michael Yeaman, professor of medicine in the Division of […]

Video – Spotlight on Stem Cell Research: Devic’s Disease (NMO) – Candace Coffee

Candace Coffee spoke at the “Spotlight on Devic’s Disease (NMO),” an educational event presented at the CIRM Governing Board meeting on October 21, 2010. Coffee is a patient advocate for NMO and stem cell therapy. Coffee was introduced by Benjamin Greenberg, director of the Neuromyelitis Optica Program at the University of Texas, Southwestern Medical School […]

Progress and Promise in Macular Degeneration

Macular degeneration is a disease associated with aging that gradually destroys sharp central vision, making it impossible to see faces, to read, or to drive. No therapy exists for the most common, or “dry”, form of the disease. Mark Humayun, professor of ophthalmology & biomedical engineering at the Doheny Eye Institute, University of Southern California, […]

Spotlight on Macular Degeneration: Welcoming Remarks

Robert Klein, J.D. and Carmen Puliafito, M.D., M.B.A., gave the welcoming remarks for the “Spotlight on Macular Degeneration,” an educational event presented at the CIRM Governing Board meeting on April 29, 2009. Klein is Chair of the CIRM Governing Board and President of Klein Financial Corporation. Puliafito is dean of the Keck School of Medicine […]

Spotlight on Macular Degeneration: Seminar by David Hinton, M.D.

David Hinton, M.D., spoke at the “Spotlight on Macular degeneration,” an educational event presented at the CIRM Governing Board meeting on April 29, 2009. Hinton has a CIRM grant to study the therapeutic potential of retinal pigment epithelial cell lines derived from human embryonic stem cells for retinal degeneration. Hinton is a professor of pathology, […]